3D-QSAR and molecular docking studies of benzaldehyde thiosemicarbazone, benzaidehyde, benzoic acid, and their derivatives as phenoloxidase inhibitors

被引:50
|
作者
Xue, Chao-Bin
Zhang, Li
Luo, Wan-Chun [1 ]
Xie, Xian-Ye
Jiang, Lin
Xiao, Ting
机构
[1] Shandong Agr Univ, Coll Plant Protect, Key Lab Pesticide Toxicol & Appl Tech, Shandong 271018, Peoples R China
[2] Cent China Normal Univ, Key Lab Pesticide & Chem Biol, Minist Educ, Wuhan 430079, Peoples R China
[3] Cent China Normal Univ, Coll Chem, Wuhan 430079, Peoples R China
[4] Shandong Agr Univ, Coll Chem & Mat Sci, Shandong 271018, Peoples R China
关键词
3D-QSAR; molecular docking; phenoloxidase; benzaldehyde thiosemicarbazone derivatives; CoMFA; CoMSIA;
D O I
10.1016/j.bmc.2006.12.038
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Phenoloxidase (PO), also known as tyrosinase, is a key enzyme in insect development, responsible for catalyzing the hydroxylation of tyrosine into o-diphenols and the oxidation of o-diphenols into o-quinones. Inhibition of PO may provide a basis for novel environmentally friendly insecticides. In the present study, we determined the inhibitory activities and IC50 values of 57 compounds belonging to the benzaldehyde thiosemicarbazone, benzaldehyde, and benzoic acid families against phenoloxidase from Pieris rapae (Lepidoptera) larvae. In addition, the inhibitory kinetics of 4-butylbenzaldehyde thiosemicarbazone against PO was measured in air-saturated solutions for the oxidation of L-3,4-dihydroxyphenylalanine (L-DOPA). The results indicated that the compound is a reversible noncompetitive inhibitor. The bioactivity results were used to construct three-dimensional quantitative structure-activity relationship (3D-QSAR) models using two molecular field analysis techniques: comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA). After carrying out superimposition using common substructure-based alignment, robust and predictive 3D-QSAR models were obtained from CoMFA (q(2) = 0.926, r(2) = 0.986) and CoMSIA (q(2) = 0.933, r(2) = 0.984) with six optimum components. The 3D-QSAR model built here will provide hints for the design of novel PO inhibitors. The molecular interactions between the ligands and the target were studied using a flexible docking method (FlexX). The best scored candidates were docked flexibly, and the interaction between the representative compound 4-butylbenzaldehyde thiosemicarbazone and the active site was elucidated in detail. (c) 2007 Published by Elsevier Ltd.
引用
收藏
页码:2006 / 2015
页数:10
相关论文
共 50 条
  • [31] Molecular docking and 3D-QSAR studies on the MAPKAP-K2 inhibitors
    Pourbasheer, Eslam
    Bazl, Roya
    Amanlou, Massoud
    MEDICINAL CHEMISTRY RESEARCH, 2014, 23 (05) : 2252 - 2263
  • [32] Molecular docking and 3D-QSAR studies of HIV-1 protease inhibitors
    Vijay M. Khedkar
    Premlata K. Ambre
    Jitender Verma
    Mushtaque S. Shaikh
    Raghuvir R. S. Pissurlenkar
    Evans C. Coutinho
    Journal of Molecular Modeling, 2010, 16 : 1251 - 1268
  • [33] Molecular Docking and 3D-QSAR Studies on Quinolone-based HDAC Inhibitors
    Bi, Yi
    Liu, Zeyun
    Liu, Xianxuan
    Zhang, Xiaochen
    Lu, Jing
    LETTERS IN DRUG DESIGN & DISCOVERY, 2016, 13 (07) : 577 - 586
  • [34] Molecular docking and receptor-specific 3D-QSAR studies of acetylcholinesterase inhibitors
    Pran Kishore Deb
    Anuradha Sharma
    Poonam Piplani
    Raghuram Rao Akkinepally
    Molecular Diversity, 2012, 16 : 803 - 823
  • [35] Molecular docking and 3D-QSAR studies on the MAPKAP-K2 inhibitors
    Eslam Pourbasheer
    Roya Bazl
    Massoud Amanlou
    Medicinal Chemistry Research, 2014, 23 : 2252 - 2263
  • [36] MOLECULAR DOCKING AND 3D-QSAR ANALYSIS STUDIES OF MMP-12 INHIBITORS
    Gunda, Shravan Kumar
    Akula, Lokesh Kumar
    Shaik, Salwa
    Bandi, Seshagiri
    Shaik, Mahmood
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2015, 6 (05): : 2019 - 2027
  • [37] 3D-QSAR and Molecular Docking Studies of Pyrimidine-based EGFR Inhibitors
    Gao, Hui
    Liu, Hong
    Hou, Jingxuan
    Gu, Qingshan
    Shi, Meiqi
    Wu, Qingkun
    Zheng, Lu
    LETTERS IN DRUG DESIGN & DISCOVERY, 2024, 21 (14) : 3049 - 3059
  • [38] Molecular docking and receptor-specific 3D-QSAR studies of acetylcholinesterase inhibitors
    Deb, Pran Kishore
    Sharma, Anuradha
    Piplani, Poonam
    Akkinepally, Raghuram Rao
    MOLECULAR DIVERSITY, 2012, 16 (04) : 803 - 823
  • [39] Molecular docking and 3D-QSAR studies of HIV-1 protease inhibitors
    Khedkar, Vijay M.
    Ambre, Premlata K.
    Verma, Jitender
    Shaikh, Mushtaque S.
    Pissurlenkar, Raghuvir R. S.
    Coutinho, Evans C.
    JOURNAL OF MOLECULAR MODELING, 2010, 16 (07) : 1251 - 1268
  • [40] 3D-QSAR and molecular docking studies of hydroxamic acids as peptide deformylase inhibitors
    Gao, Jian
    Cheng, Yuanhua
    Cui, Wei
    Chen, Quan
    Zhang, Fushi
    Du, Yuguo
    Ji, Mingjuan
    MEDICINAL CHEMISTRY RESEARCH, 2012, 21 (08) : 1597 - 1610